← Research hub  ·  securities

ESPR · Esperion Therapeutics

My allocationNot heldas of 2026-SEP-03 · allocation page ↗
Research: QT · SA · STK · FA2 mentions
2026-JUN-21 · Jay Singh · Weekly SSR research call (premium) · Neutralmention · source page ↗$3.17

In short: Arb housekeeping: cleared HSR.

Full passage: premium transcript (PDF).

SOD $3.17 (open 2026-JUN-18)
2026-JUN-14 · Jay Singh · Weekly SSR research call (premium) · Neutralmention · source page ↗$3.14

In short: Arb housekeeping: received German FCO approval; its HSR antitrust waiting period expires June 15.

Full passage: premium transcript (PDF).

SOD $3.14 (open 2026-JUN-12)

Nothing matches this filter.

Verbatim excerpts from the public transcripts (auto-pulled at each mention's timestamp, lightly cleaned). Timestamps link into the video; "source page" opens that commentator's full analysis at this row. Click a mention's header line to expand it (one open at a time). For personal study — not investment advice.